Skip to main content

Peer Review reports

From: Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL

Original Submission
12 Jan 2018 Submitted Original manuscript
21 Feb 2018 Reviewed Reviewer Report - Xiaohe Yang
5 Apr 2018 Reviewed Reviewer Report - Rosario Yerbes
11 Apr 2018 Reviewed Reviewer Report - Richard J Bold
10 May 2018 Author responded Author comments - Alex Eustace
Resubmission - Version 2
10 May 2018 Submitted Manuscript version 2
28 May 2018 Reviewed Reviewer Report - Xiaohe Yang
2 Jun 2018 Reviewed Reviewer Report - Richard J Bold
19 Jun 2018 Author responded Author comments - Alex Eustace
Resubmission - Version 3
19 Jun 2018 Submitted Manuscript version 3
2 Jul 2018 Reviewed Reviewer Report - Xiaohe Yang
19 Sep 2018 Author responded Author comments - Alex Eustace
Resubmission - Version 4
19 Sep 2018 Submitted Manuscript version 4
Publishing
24 Sep 2018 Editorially accepted
11 Oct 2018 Article published 10.1186/s12885-018-4852-1

You can find further information about peer review here.

Back to article page